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Dear Editor
Hypersensitivity to Fludrocortisone
Acetate in a Recipient of Bone
Marrow Transplantation
Fludrocortisone acetate, a 9α-fluorinated derivative of
hydrocortisone, is a synthetic steroid possessing a
predominantly high level of mineralocorticoid activ-
ity.1 It is generally used in replacement therapy for
adrenocortical insufficiency, such as Addison’s dis-
ease, as well as in the treatment of salt-losing adreno-
genital syndrome and less frequently for orthostatic
hypotension. Since fludrocortisone acetate is a ster-
oid, it is plausible that it has little potential to cause a
hypersensitivity reaction. Indeed, to the best of our
knowledge, there are no reported cases of hypersen-
sitivity to fludrocortisone acetate in the English-
language literature. We herein present the first case
of hypersensitivity to fludrocortisone acetate.
A 23-year-old man with acute myeloid leukaemia
underwent bone marrow transplantation from an un-
related donor after being conditioned with total body
irradiation and high-dose cytarabine. Around post-
transplant day 180, he developed orthostatic hypoten-
sion, which seriously impaired his daily life activities.
Treatment with midodrine hydrochloride and amez-
inium metilsulfate yielded no improvement of his hy-
potension symptoms. Fludrocortisone acetate was
then administered orally at a daily dose of 0.1 mg.
Two days after he commenced fludrocortisone ace-
tate treatment, he developed a high-grade fever and
sharply marginated, infiltrative, erythematous skin
eruptions. These eruptions distributed on the face,
trunk, and all extremities, but not involved mucous
membranes. The laboratory findings were remark-
able: a white blood cell count of 5.5 × 109L with 23%
eosinophils and an elevated C-reactive protein value
(2.69 mgdl). A drug-induced lymphocyte stimulation
test ( DLST ) for fludrocortisone acetate was per-
formed by the 3H-thymidine absorption method. 2
DLST was positive for fludrocortisone acetate with a
stimulating index of 281% . Neither patch test nor
provocation test was performed. Based on these find-
ings, the diagnosis of drug hypersensitivity caused by
fludrocortisone acetate was made. Fludrocortisone
acetate treatment was discontinued. Defervescence
was then obtained within 2 days, and the erythema
completely disappeared within 10 days. Fludrocorti-
sone acetate was not readministered thereafter, and
any other types of steroid preparations were not
given for the treatment of orthostatic hypotension.
In the present case, fludrocortisone acetate caused
a severe hypersensitivity reaction, presenting as gen-
eralized erythema. In general, it is difficult to defi-
nitely determine which drug causes a hypersensitiv-
ity reaction unless only a single agent is given. In fact,
our case received several drugs at the onset of gener-
alized erythema. However, all the drugs except flu-
drocortisone acetate had been initiated at least one
month before and were continued even after the pa-
tient had developed generalized erythema. Based on
such a clinical course together with the positive re-
sults of DLST, we conclude that fludrocortisone ace-
tate caused the hypersensitivity reaction in our case.
While the prominent characteristic of fludrocorti-
sone acetate is a high mineralocorticoid activity (125
times the potency of cortisol), it also possesses mod-
erate glucocorticoid activity (10 times the potency of
cortisol).3 Therefore, during the administration of flu-
drocortisone acetate, warnings are necessary for hy-
pertension, hypernatremia, hypokalemia, and water
retention due to mineralocorticoid activity ; and for
impaired glucose tolerance and psychiatric reaction
due to glucorticoid activity. We believe that the pre-
sent case is the first report documenting hypersensi-
tivity to fludrocortisone acetate, while there have
been reported cases of hypersensitivity to other types
of steroid preparations such as hydrocortisone and
methylprednisolone.4 Although most of the reported
cases of hypersensitivity to steroid were due to
immediate-type hypersensitivity, it is notable that the
present case manifested as delayed-type hypersensi-
tivity. Our findings strongly suggest that fludrocorti-
sone acetate, a synthetic steroid, may be antigenic
and cause hypersensitivity in spite of its pharma-
cologic activity not only as a mineralocorticoid but
also as a glucocorticoid. However, impaired immunity
due immune reconstitution after allogeneic bone mar-
row transplantation might have also played some role
in the development of hypersensitivity to the drug.
We conclude that physicians should be aware of
hypersensitivity as an adverse effect of fludrocorti-
sone acetate. An accumulation of such cases is
needed to further elucidate the characteristics and
epidemiology of this rare adverse effect.
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